1. DeLellis RA, Al Ghuzlan A, Albores Saavedra J, Baloch ZW, Basolo F, Elisei R, Kaserer K, LiVolsi VA, Matias-Guiu X, Mete O, Moley JF, Nikiforov YE, Nose V, Pinto AE. Medullary thyroid carcinoma. In: Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th ed. Lyon: IARC; 2017. p. 108–13.
2. Beskid M, Dabska M, Klos H, Majdecki T. Histochemical features of C-cell thyroid carcinoma. Acta Histochem. 1977;58(2):210–8. https://doi.org/10.1016/S0065-1281(77)80131-1. Epub 1977/01/01. PubMed PMID: 197764
3. Argemi B, Sudan N, Fayet G, Codaccioni JL. Ultrastructure, biological study and culture of C-cell carcinoma of the thyroid gland. Biomedicine. 1976;24(5):352–8. Epub 1976/11/10. PubMed PMID: 1000020
4. Dyhdalo KS, Chute DJ. Barriers to the recognition of medullary thyroid carcinoma on FNA: implications relevant to the new American Thyroid Association guidelines. Cancer Cytopathol. 2018;126(6):397–405. https://doi.org/10.1002/cncy.21990. Epub 2018/03/27. PubMed PMID: 29579362
5. Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal ML. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225–34. https://doi.org/10.1016/S2213-8587(21)00027-9. Epub 2021/03/05. PubMed PMID: 33662333